Risk assessment for hepatic veno-occlusive disease in patients treated with gemtuzumab ozogamicin (Mylotarg (R)) with or without hematopoietic stem cell transplantation.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Erba, HP; Stadtmauer, EA; Larson, RA; Sievers, EL; Esrey, EH; Lowenberg, B; Sherman, ML; Herbertson, RK; Appelbaum, FR

Published Date

  • November 16, 2003

Published In

Volume / Issue

  • 102 / 11

Start / End Page

  • 871A - 871A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 45th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • SAN DIEGO, CALIFORNIA

Conference Start Date

  • December 6, 2003

Conference End Date

  • December 9, 2003